SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-24-000027
Filing Date
2024-02-05
Accepted
2024-02-05 19:54:49
Documents
1
Period of Report
2024-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1707180869.html 4  
1 FORM 4 wk-form4_1707180869.xml 4 7847
  Complete submission text file 0001447028-24-000027.txt   9489
Mailing Address C/O ARBUTUS BIOPHARMA 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
HASTINGS DAVID C (Reporting) CIK: 0001237401 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 24597686

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)